MICM
LEGN icon

Matthews International Capital Management’s Legend Biotech LEGN Stock Holding History

Matthews International Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Sell
917,266
-8,654
-0.9% -$233K 9.08% 3
2026
Q1 		$16.7M Sell
925,920
-30,904
-3% -$589K 6.8% 4
2025
Q4 		$20.8M Sell
956,824
-71,623
-7% -$2.05M 6.31% 4
2025
Q3 		$33.5M Sell
1,028,447
-264,605
-20% -$9.77M 7.81% 3
2025
Q2 		$45.9M Buy
1,293,052
+191,165
+17% +$6.19M 10.56% 3
2025
Q1 		$37.4M Sell
1,101,887
-83,629
-7% -$3M 7.72% 4
2024
Q4 		$38.6M Buy
1,185,516
+153,665
+15% +$6.37M 7.89% 3
2024
Q3 		$50.3M Buy
1,031,851
+9,071
+0.9% +$483K 8.28% 5
2024
Q2 		$45.3M Buy
1,022,780
+270,845
+36% +$12.5M 9.86% 3
2024
Q1 		$42.2M Sell
751,935
-57,639
-7% -$3.48M 8.31% 3
2023
Q4 		$48.7M Sell
809,574
-314,254
-28% -$19.9M 6.84% 5
2023
Q3 		$75.5M Buy
1,123,828
+136
+0% +$9.45K 9.13% 4
2023
Q2 		$77.6M Sell
1,123,692
-182,976
-14% -$12M 9.09% 3
2023
Q1 		$63M Buy
1,306,668
+134,900
+12% +$6.6M 6.29% 4
2022
Q4 		$58.5M Sell
1,171,768
-294,685
-20% -$14.3M 6.91% 4
2022
Q3 		$59.8M Buy
1,466,453
+244,111
+20% +$11.5M 8.69% 3
2022
Q2 		$67.2M Buy
1,222,342
+121,800
+11% +$5.14M 9.65% 3
2022
Q1 		$40M Buy
1,100,542
+95,800
+10% +$3.79M 5.54% 6
2021
Q4 		$46.8M Sell
1,004,742
-351,800
-26% -$17.8M 4.89% 7
2021
Q3 		$68.6M Buy
1,356,542
+14,100
+1% +$587K 4.16% 8
2021
Q2 		$55.1M Buy
1,342,442
+288,200
+27% +$9.8M 2.29% 13
2021
Q1 		$30.6M Buy
1,054,242
+279,000
+36% +$7.61M 1.28% 20
2020
Q4 		$21.8M Sell
775,242
-193,620
-20% -$5.57M 1.16% 22
2020
Q3 		$29.9M Sell
968,862
-229,621
-19% -$7.73M 2.02% 16
2020
Q2 		$51M Buy
+1,198,483
New +$46.8M 3.96% 8

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Matthews International Capital Management's LEGN Position: Q2 2026 in Review

Matthews International Capital Management reduced its Legend Biotech (LEGN) stake by 0.93% in Q2 2026, selling an estimated $233K and leaving 917,266 shares worth $26.5M. The position accounts for 9.08% of the portfolio, ranked #3.

Matthews International Capital Management first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $77.6M in Q2 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Matthews International Capital Management held 917,266 shares of Legend Biotech worth $26.5M as of Q2 2026.
  • Matthews International Capital Management sold 8,654 Legend Biotech shares in Q2 2026, an estimated $233K.
  • Legend Biotech made up 9.08% of Matthews International Capital Management's portfolio in Q2 2026, its #3 holding.
  • Matthews International Capital Management first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • Matthews International Capital Management's Legend Biotech position peaked at $77.6M in Q2 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Matthews International Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.